Canada · Delayed Price · Currency is CAD Organigram Global Earnings Call Transcripts
Fiscal Year 2026
-
Record quarterly revenue and adjusted EBITDA were achieved, driven by the Sanity Group acquisition and strong Canadian operations. International revenue now exceeds one-third of total revenue, with robust growth in flower, vapes, and beverages. Margin expansion and positive Q4 free cash flow are expected.
-
Q2 fiscal 2026 saw revenue and margin declines due to operational issues and market softness, but remediation efforts and the Sanity Group acquisition are expected to drive stronger performance in the second half. Guidance for fiscal 2026 projects net revenue above CAD 350 million and improved profitability.
-
Q1 saw 49% year-over-year revenue growth and a 273% rise in adjusted EBITDA, with stable margins despite seasonal and operational headwinds. Market share leadership was maintained in Canada, while international sales grew but faced temporary setbacks due to out-of-spec product.
Fiscal Year 2025
-
Record revenue, margin, and EBITDA were achieved, driven by Canadian market leadership, Motif Labs integration, and surging international sales. Fiscal 2026 guidance calls for over CAD 300 million in revenue, margin expansion, and strong global growth.
-
Record Q3 revenue and market share gains were driven by strong domestic brands and international expansion, despite temporary ERP integration challenges. Adjusted EBITDA rose 64% year-over-year, and the company expects further margin improvement and positive free cash flow ahead.
-
Record Q2 revenue and net income were driven by strong Canadian market share, international sales growth, and successful integration of Motif and Collective Project. Margin expansion, increased capacity, and strategic investments position the business for continued growth.
-
The company has solidified its position as Canada's market leader through strategic acquisitions, operational efficiency, and innovation, with a strong focus on international expansion and regulatory advocacy. Financial performance is improving, and management anticipates continued growth and margin expansion in fiscal 2025.
-
Q3 saw 25% year-over-year net revenue growth, a return to positive adjusted EBITDA, and a 36% adjusted gross margin. Strategic investments in Germany and seed-based production are expected to drive future growth, with a strong balance sheet supporting expansion.
Fiscal Year 2024
-
Fiscal 2024 saw strong revenue and margin growth, driven by operational efficiencies, innovation, and strategic acquisitions. The Motif acquisition positions the company as Canada's top producer, while international expansion and new technologies like FAST support future growth.
-
Net revenue grew 25% year-over-year and 9% sequentially, with adjusted gross margin rising to 36%. International expansion advanced with a major investment in Germany, while cost savings and operational efficiencies drove profitability.